{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:03:52Z","timestamp":1791083032199,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T00:00:00Z","timestamp":1708646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-024-01104-4","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T18:01:57Z","timestamp":1708711317000},"page":"3819-3830","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exclusion of older patients from randomized clinical trials in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"given":"Danuta","family":"K\u0142osowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Fiszer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"Dulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"G\u00f3rski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Borysowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"1104_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE. Parkinson\u2019s disease. Lancet. 2015;386:896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3.","journal-title":"Lancet"},{"key":"1104_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jamaneurol.2022.1783","volume":"79","author":"N Schiess","year":"2022","unstructured":"Schiess N, Cataldi R, Okun MS, et al. Six action steps to address global disparities in Parkinson disease: a World Health Organization priority. JAMA Neurol. 2022;79:929\u201336. https:\/\/doi.org\/10.1001\/jamaneurol.2022.1783.","journal-title":"JAMA Neurol"},{"issue":"s1","key":"1104_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Sherer T, Okun MS, Bloem BR. The emerging evidence of the Parkinson pandemic. J Parkinsons Dis. 2018;8(s1):S3\u20138. https:\/\/doi.org\/10.3233\/JPD-181474.","journal-title":"J Parkinsons Dis"},{"key":"1104_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.arr.2014.01.004","volume":"14","author":"A Reeve","year":"2014","unstructured":"Reeve A, Simcox E, Turnbull D. Ageing and Parkinson\u2019s disease: why is advancing age the biggest risk factor? Ageing Res Rev. 2014;14:19\u201330. https:\/\/doi.org\/10.1016\/j.arr.2014.01.004.","journal-title":"Ageing Res Rev"},{"key":"1104_CR5","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TD. The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord. 2014;29:1583\u201390. https:\/\/doi.org\/10.1002\/mds.25945.","journal-title":"Mov Disord"},{"key":"1104_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1159\/000445751","volume":"46","author":"L Hirsch","year":"2016","unstructured":"Hirsch L, Jette N, Frolkis A, et al. The incidence of Parkinson\u2019s disease: a systematic review and meta-analysis. Neuroepidemiology. 2016;46:292\u2013300. https:\/\/doi.org\/10.1159\/000445751.","journal-title":"Neuroepidemiology"},{"key":"1104_CR7","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","volume":"15","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Schwarzschild MA. The epidemiology of Parkinson\u2019s disease: risk factors and prevention. Lancet Neurol. 2016;15:1257\u201372. https:\/\/doi.org\/10.1016\/S1474-4422(16)30230-7.","journal-title":"Lancet Neurol"},{"key":"1104_CR8","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1111\/bcp.14539","volume":"86","author":"RJ van Marum","year":"2020","unstructured":"van Marum RJ. Underrepresentation of the elderly in clinical trials, time for action. Br J Clin Pharmacol. 2020;86:2014\u20136. https:\/\/doi.org\/10.1111\/bcp.14539.","journal-title":"Br J Clin Pharmacol"},{"key":"1104_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5603\/PJNNS.a2021.0040","volume":"55","author":"M Kwa\u015bniak-Butowska","year":"2021","unstructured":"Kwa\u015bniak-Butowska M, Dulski J, Pierzchli\u0144ska A, Bia\u0142ecka M, Wieczorek D, S\u0142awek J. Cardiovascular dysautonomia and cognition in Parkinson\u2019s disease - a possible relationship. Neurol Neurochir Pol. 2021;55:525\u201335. https:\/\/doi.org\/10.5603\/PJNNS.a2021.0040.","journal-title":"Neurol Neurochir Pol"},{"key":"1104_CR10","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1002\/mdc3.13161","volume":"8","author":"P Azevedo","year":"2021","unstructured":"Azevedo P, Aquino CC, Fasano A. Surgical management of Parkinson\u2019s disease in the elderly. Mov Disord Clin Pract. 2021;8:500\u20139. https:\/\/doi.org\/10.1002\/mdc3.13161.","journal-title":"Mov Disord Clin Pract"},{"key":"1104_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0261302","volume":"16","author":"S Virameteekul","year":"2021","unstructured":"Virameteekul S, Phokaewvarangkul O, Bhidayasiri R. Profiling the most elderly parkinson\u2019s disease patients: does age or disease duration matter? PLoS ONE. 2021;16: e0261302. https:\/\/doi.org\/10.1371\/journal.pone.0261302.","journal-title":"PLoS ONE"},{"key":"1104_CR12","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1007\/s13311-020-00960-0","volume":"17","author":"PA Vaswani","year":"2020","unstructured":"Vaswani PA, Tropea TF, Dahodwala N. Overcoming barriers to Parkinson disease trial participation: increasing diversity and novel designs for recruitment and retention. Neurotherapeutics. 2020;17:1724\u201335. https:\/\/doi.org\/10.1007\/s13311-020-00960-0.","journal-title":"Neurotherapeutics"},{"key":"1104_CR13","doi-asserted-by":"publisher","first-page":"afab282","DOI":"10.1093\/ageing\/afab282","volume":"51","author":"KH Pitkala","year":"2022","unstructured":"Pitkala KH, Strandberg TE. Clinical trials in older people. Age Ageing. 2022;51:afab282. https:\/\/doi.org\/10.1093\/ageing\/afab282.","journal-title":"Age Ageing"},{"issue":"Suppl 1","key":"1104_CR14","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.2105\/AJPH.2009.162982","volume":"100 Suppl 1","author":"AP Herrera","year":"2010","unstructured":"Herrera AP, Snipes SA, King DW, et al. Disparate inclusion of older adults in clinical trials: priorities and opportunities for policy and practice change. Am J Public Health. 2010;100 Suppl 1(Suppl 1):S105-12. https:\/\/doi.org\/10.2105\/AJPH.2009.162982.","journal-title":"Am J Public Health"},{"key":"1104_CR15","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1111\/jgs.16875","volume":"68","author":"ND Forsat","year":"2020","unstructured":"Forsat ND, Palmowski A, Palmowski Y, et al. Recruitment and retention of older people in clinical research: a systematic literature review. J Am Geriatr Soc. 2020;68:2955\u201363. https:\/\/doi.org\/10.1111\/jgs.16875.","journal-title":"J Am Geriatr Soc"},{"key":"1104_CR16","doi-asserted-by":"publisher","first-page":"k1452","DOI":"10.1136\/bmj.k1452","volume":"361","author":"T Tse","year":"2018","unstructured":"Tse T, Fain KM, Zarin DA. How to avoid common problems when using ClinicalTrials.gov in research: 10 issues to consider. BMJ. 2018;361:k1452. https:\/\/doi.org\/10.1136\/bmj.k1452.","journal-title":"BMJ"},{"key":"1104_CR17","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamainternmed.2020.5084","volume":"180","author":"BKI Helfand","year":"2020","unstructured":"Helfand BKI, Webb M, Gartaganis SL, et al. The exclusion of older persons from vaccine and treatment trials for coronavirus disease 2019-missing the target. JAMA Intern Med. 2020;180:1546\u20139. https:\/\/doi.org\/10.1001\/jamainternmed.2020.5084.","journal-title":"JAMA Intern Med"},{"key":"1104_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1634\/theoncologist.2017-0687","volume":"24","author":"N Duma","year":"2019","unstructured":"Duma N, Kothadia SM, Azam TU, et al. Characterization of comorbidities limiting the recruitment of patients in early phase clinical trials. Oncologist. 2019;24:96\u2013102. https:\/\/doi.org\/10.1634\/theoncologist.2017-0687.","journal-title":"Oncologist"},{"key":"1104_CR19","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1111\/jgs.14833","volume":"65","author":"FT Bourgeois","year":"2017","unstructured":"Bourgeois FT, Orenstein L, Ballakur S, et al. Exclusion of elderly people from randomized clinical trials of drugs for ischemic heart disease. J Am Geriatr Soc. 2017;65:2354\u201361. https:\/\/doi.org\/10.1111\/jgs.14833.","journal-title":"J Am Geriatr Soc"},{"key":"1104_CR20","unstructured":"International Parkinson and Movement Disorder Sociaty. Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS). Available at: https:\/\/www.movementdisorders.org\/MDS\/MDS-Rating-Scales\/MDS-Unified-Parkinsons-Disease-Rating-Scale-MDS-UPDRS.htm Accessed February 1, 2023"},{"key":"1104_CR21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/jgs.12215","volume":"61","author":"AJ Cruz-Jentoft","year":"2013","unstructured":"Cruz-Jentoft AJ, Carpena-Ruiz M, Montero-Errasqu\u00edn B, et al. Exclusion of older adults from ongoing clinical trials about type 2 diabetes mellitus. J Am Geriatr Soc. 2013;61:734\u20138. https:\/\/doi.org\/10.1111\/jgs.12215.","journal-title":"J Am Geriatr Soc"},{"key":"1104_CR22","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1200\/JCO.2003.08.010","volume":"21","author":"JH Lewis","year":"2003","unstructured":"Lewis JH, Kilgore ML, Goldman DP, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol. 2003;21:1383\u20139. https:\/\/doi.org\/10.1200\/JCO.2003.08.010.","journal-title":"J Clin Oncol"},{"key":"1104_CR23","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1634\/theoncologist.2014-0093","volume":"19","author":"ME Hamaker","year":"2014","unstructured":"Hamaker ME, Stauder R, van Munster BC. Exclusion of older patients from ongoing clinical trials for hematological malignancies: an evaluation of the National Institutes of Health Clinical Trial Registry. Oncologist. 2014;19:1069\u201375. https:\/\/doi.org\/10.1634\/theoncologist.2014-0093.","journal-title":"Oncologist"},{"key":"1104_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.945481","volume":"9","author":"K Krysa","year":"2022","unstructured":"Krysa K, Kowalczyk E, Borysowski J, et al. Exclusion of older adults from clinical trials in cancer-related pain. Front Med (Lausanne). 2022;9: 945481. https:\/\/doi.org\/10.3389\/fmed.2022.945481.","journal-title":"Front Med (Lausanne)"},{"key":"1104_CR25","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/gerona\/glt162","volume":"69","author":"DJ Lowsky","year":"2014","unstructured":"Lowsky DJ, Olshansky SJ, Bhattacharya J, Goldman DP. Heterogeneity in healthy aging. J Gerontol A Biol Sci Med Sci. 2014;69:640\u20139. https:\/\/doi.org\/10.1093\/gerona\/glt162.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"1104_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","volume":"4","author":"C Marras","year":"2018","unstructured":"Marras C, Beck JC, Bower JH, Roberts E, Ritz B, Ross GW, Abbott RD, Savica R, Van Den Eeden SK, Willis AW, Tanner CM. Parkinson\u2019s Foundation P4 Group. Prevalence of Parkinson\u2019s disease across North America. NPJ Parkinsons Dis. 2018;4:21. https:\/\/doi.org\/10.1038\/s41531-018-0058-0.","journal-title":"NPJ Parkinsons Dis"},{"key":"1104_CR27","unstructured":"Caplan Z. 2020 Census: 1 in 6 People in the United States Were 65 and Over. Washington: United States Census Bureau; https:\/\/www.census.gov\/library\/stories\/2023\/05\/2020-census-united-states-older-population-grew.html Accessed July 10, 2023"},{"key":"1104_CR28","unstructured":"Food and Drug Administration. General considerations for the clinical evaluation of drugs. Guidance for Industry. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/general-considerations-clinical-evaluation-drugs Accessed January 26, 2023"},{"key":"1104_CR29","unstructured":"Food and Drug Administration. Study of drugs likely to be used in the elderly. Guidance for Industry. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/study-drugs-likely-be-used-elderly Accessed January 26, 2023"},{"key":"1104_CR30","unstructured":"Food and Drug Administration. Evaluating inclusion and exclusion criteria in clinical trials. Workshop report. The National Press Club, Washington DC, April 16, 2018. Food and Drug Administration. Available at: https:\/\/www.fda.gov\/media\/134754\/download Accessed January 26, 2023"},{"key":"1104_CR31","unstructured":"European Medicines Agency. Medicines for older people. Available at: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/research-development\/medicines-older-people Accessed February 6, 2023."},{"key":"1104_CR32","unstructured":"National Institutes of Health. Inclusion across the lifespan. Available at: https:\/\/grants.nih.gov\/policy\/inclusion\/lifespan.htm Accessed January 27, 2023"},{"key":"1104_CR33","unstructured":"Regulation (EU) No 536\/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001\/20\/EC Text with EEA relevance. https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=celex%3A32014R0536 Accessed January 27, 2023"},{"key":"1104_CR34","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.parkreldis.2012.03.003","volume":"18","author":"PR Fitzsimmons","year":"2012","unstructured":"Fitzsimmons PR, Blayney S, Mina-Corkill S, Scott GO. Older participants are frequently excluded from Parkinson\u2019s disease research. Parkinsonism Relat Disord. 2012;18:585\u20139. https:\/\/doi.org\/10.1016\/j.parkreldis.2012.03.003.","journal-title":"Parkinsonism Relat Disord"},{"key":"1104_CR35","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1111\/j.1532-5415.2008.02024.x","volume":"56","author":"A Rajapakse","year":"2008","unstructured":"Rajapakse A, Rajapakse S, Playfer J. Age bias in clinical trials of Parkinson\u2019s disease treatment. J Am Geriatr Soc. 2008;56:2353\u20134. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.02024.x.","journal-title":"J Am Geriatr Soc"},{"key":"1104_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","volume":"13","author":"D Aarsland","year":"2017","unstructured":"Aarsland D, Creese B, Politis M, et al. Cognitive decline in Parkinson disease. Nat Rev Neurol. 2017;13:217\u201331. https:\/\/doi.org\/10.1038\/nrneurol.2017.27.","journal-title":"Nat Rev Neurol"},{"key":"1104_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11910-018-0823-9","volume":"18","author":"RS Weil","year":"2018","unstructured":"Weil RS, Costantini AA, Schrag AE. Mild cognitive impairment in Parkinson\u2019s disease-what is it? Curr Neurol Neurosci Rep. 2018;18:17. https:\/\/doi.org\/10.1007\/s11910-018-0823-9.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1104_CR38","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.nrl.2013.07.003","volume":"29","author":"C Carnero-Pardo","year":"2014","unstructured":"Carnero-Pardo C. Should the mini-mental state examination be retired? Neurologia. 2014;29:473\u201381. https:\/\/doi.org\/10.1016\/j.nrl.2013.07.003.","journal-title":"Neurologia"},{"issue":"16","key":"1104_CR39","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1002\/mds.21844","volume":"22","author":"B Dubois","year":"2007","unstructured":"Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M. Diagnostic procedures for Parkinson\u2019s disease dementia: recommendations from the movement disorder society task force. Mov Disord. 2007;22(16):2314\u201324. https:\/\/doi.org\/10.1002\/mds.21844.","journal-title":"Mov Disord"},{"issue":"3","key":"1104_CR40","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/mds.24893","volume":"27","author":"I Litvan","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M. Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27(3):349\u201356. https:\/\/doi.org\/10.1002\/mds.24893.","journal-title":"Mov Disord"},{"key":"1104_CR41","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11910-013-0409-5","volume":"13","author":"L Marsh","year":"2013","unstructured":"Marsh L. Depression and Parkinson\u2019s disease: current knowledge. Curr Neurol Neurosci Rep. 2013;13:409. https:\/\/doi.org\/10.1007\/s11910-013-0409-5.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1104_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114511","volume":"311","author":"T Hu","year":"2022","unstructured":"Hu T, Zhao X, Wu M, Li Z, Luo L, Yang C, Yang F. Prevalence of depression in older adults: a systematic review and meta-analysis. Psychiatry Res. 2022;311: 114511. https:\/\/doi.org\/10.1016\/j.psychres.2022.114511.","journal-title":"Psychiatry Res"},{"key":"1104_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.prdoa.2021.100095","volume":"4","author":"JM McMillan","year":"2021","unstructured":"McMillan JM, Michalchuk Q, Goodarzi Z. Frailty in Parkinson\u2019s disease: a systematic review and meta-analysis. Clin Park Relat Disord. 2021;4: 100095. https:\/\/doi.org\/10.1016\/j.prdoa.2021.100095.","journal-title":"Clin Park Relat Disord"},{"key":"1104_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s40520-018-1004-z","volume":"31","author":"AL Mazya","year":"2019","unstructured":"Mazya AL, Garvin P, Ekdahl AW. Outpatient comprehensive geriatric assessment: effects on frailty and mortality in old people with multimorbidity and high health care utilization. Aging Clin Exp Res. 2019;31:519\u201325. https:\/\/doi.org\/10.1007\/s40520-018-1004-z.","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"1104_CR45","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3233\/JAD-220597","volume":"91","author":"M Overton","year":"2023","unstructured":"Overton M, Sj\u00f6gren B, Elmst\u00e5hl S, Rosso A. Mild cognitive impairment, reversion rates, and associated factors: comparison of two diagnostic approaches. J Alzheimers Dis. 2023;91(2):585\u2013601. https:\/\/doi.org\/10.3233\/JAD-220597.","journal-title":"J Alzheimers Dis"},{"key":"1104_CR46","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1093\/ageing\/afab147","volume":"50","author":"T Buttgereit","year":"2021","unstructured":"Buttgereit T, Palmowski A, Forsat N, et al. Barriers and potential solutions in the recruitment and retention of older patients in clinical trials-lessons learned from six large multicentre randomized controlled trials. Age Ageing. 2021;50:1988\u201396. https:\/\/doi.org\/10.1093\/ageing\/afab147.","journal-title":"Age Ageing"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-024-01104-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-024-01104-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-024-01104-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:09:57Z","timestamp":1720278597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-024-01104-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":46,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1007\/s11357-024-01104-4","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]},"assertion":[{"value":"26 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"U. F.: research funding, F. Hoffmann-La Roche Ltd. (clinical trial BN42358); lecture fee, Termedia, Medical Tribune (lectures on Parkinson\u2019s disease), honorarium for educational tests, Via Medica (tests concerning Parkinson\u2019s disease). D. K., J. D., A. G., and J. B. have nothing to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}